Overview

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Liver transplant subjects will be given Mycophenolate (MMF) and Tacrolimus in order to help prevent post-transplant rejection.
Phase:
Phase 1
Details
Lead Sponsor:
Duke University
Collaborator:
Novartis Pharmaceuticals
Treatments:
Tacrolimus